TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ +0.0% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Organon & Co (OGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,558 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement OGN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
1,519 1,598 1,622 1,607 1,582 1,592 1,513 1,594 1,602 1,507 1,460 1,558 6,127
612 683 665 668 659 696 672 720 745 748 677 711 2,881
907 915 957 939 923 896 841 874 857 759 783 847 3,246
137 134 112 116 111 130 96 95 84 91 93 90 358
497 260 431 437 422 264 420 453 415 433 424 434 1,706
675 603 543 553 533 600 516 548 499 524 517 524 2,064
232 312 414 386 390 296 325 326 358 235 266 323 1,182
134 129 131 131 126 132 124 132 128 121 111 108 468
80 104 236 235 207 129 101 229 243 -148 213 183 491
22 -442 35 40 -152 20 14 84 83 57 67 75 282
58 546 201 195 359 109 87 145 160 -205 146 108 209
275 293 432 432 402 341 325 449 460 65 410 371 1,306

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?